Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05160220

Organisation Name: National Council of Scientific and Technical Research, Argentina

Overal Status: Completed

Start Date: January 20, 2021

Last Update: December 16, 2021

Lead Sponsor: National Council of Scientific and Technical Research, Argentina

Brief Summary: This study seeks to understand the neural, cognitive and behavioral effects of low doses of psilocybin administered in the form of dried mushroom material (0.5 g of Psilocybe cubensis) consumed in natural settings following a placebo-controlled double-blind experimental design.

Conditions:
  • Cognitive Change
  • Creativity
  • Mood Change
  • Sleep


Total execution time in seconds: 0.24200296401978